{
  "risk_classes": {
    "I":   { "min_studies": 1, "min_patients": 20 },
    "IIa": { "min_studies": 2, "min_patients": 50 },
    "IIb": { "min_studies": 3, "min_patients": 100 },
    "III": { "min_studies": 4, "min_patients": 200 }
  },
  "jurisdictions": {
    "UK": {
      "agency": "MHRA",
      "notes": "Post-Brexit UKCA / CE combination space"
    },
    "EU": {
      "agency": "Notified Body",
      "notes": "MDR environment"
    },
    "US": {
      "agency": "FDA",
      "notes": "510(k) / De Novo / PMA"
    }
  }
}



